Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Trastornos del Movimiento
FILTRAR POR:
Por tema
473 ARTÍCULOS , VIENDO DEL 241 AL 255
Sleep Issues in Parkinson's Disease and Their Management
Zuzuárregui JRP, During EH.
Neurotherapeutics. 2020 Oct;17(4):1480-1494. doi: 10.1007/s13311-020-00938-y. Epub 2020 Oct 7.
Arylsulfatase A (ASA) in Parkinson's Disease: From Pathogenesis to Biomarker Potential
Angelopoulou E, Paudel YN, Villa C, Piperi C.
Brain Sci. 2020 Oct 7;10(10):713. doi: 10.3390/brainsci10100713.
Parkinsonism in Patients with Neuronopathic (Type 3) Gaucher Disease: A Case Series
Ryan E, Amato D, MacKenzie JJ, Sidransky E, Lopez G.
Mov Disord Clin Pract. 2020 Aug 17;7(7):834-837. doi: 10.1002/mdc3.13031. eCollection 2020 Oct.
History of and Insights Into Spinal Cord Stimulation in Parkinson Disease
Garcia BB, Junior ER, Araújo MFP, Simplício H.
Neurorehabil Neural Repair. 2020 Nov;34(11):967-978. doi: 10.1177/1545968320956984. Epub 2020 Oct 13.
Behavioral Tests in Neurotoxin-Induced Animal Models of Parkinson's Disease
Prasad EM, Hung SY.
Antioxidants (Basel). 2020 Oct 16;9(10):1007. doi: 10.3390/antiox9101007.
Wang Y, Wei N, Li X.
Front Aging Neurosci. 2020 Sep 25;12:277. doi: 10.3389/fnagi.2020.00277. eCollection 2020.
Functional Recovery in Parkinson's Disease: Current State and Future Perspective
Bacanoiu MV, Mititelu RR, Danoiu M, Olaru G, Buga AM.
J Clin Med. 2020 Oct 24;9(11):3413. doi: 10.3390/jcm9113413.
Stem Cell-Based Therapies for Parkinson Disease
Liu Z, Cheung HH.
Int J Mol Sci. 2020 Oct 29;21(21):8060. doi: 10.3390/ijms21218060.
Anxiety: An ignored aspect of Parkinson's disease lacking attention
Khatri DK, Choudhary M, Sood A, Singh SB.
Biomed Pharmacother. 2020 Nov;131:110776. doi: 10.1016/j.biopha.2020.110776. Epub 2020 Oct 3.
Target Selection of Directional Lead in Patients with Parkinson's Disease
Sasagawa A, Enatsu R, Kitagawa M, Mikami T, Nakayama-Kamada C, Kuribara T, Hirano T, Arihara M, Mikuni N.
Neurol Med Chir (Tokyo). 2020 Dec 15;60(12):622-628. doi: 10.2176/nmc.tn.2020-0210. Epub 2020 Nov 6.
Unilateral Resting Tremor in a Thigh Muscle in Parkinson's Disease
Park S, Choi JH, Yoon WT, Lee JY.
Tremor Other Hyperkinet Mov (N Y). 2020 Oct 19;10:44. doi: 10.5334/tohm.556.
Intrajejunal vs oral levodopa-carbidopa therapy in Parkinson disease: A retrospective cohort study
Popa LC, Leucuta DC, Tohanean N, Popa SL, Perju-Dumbrava L.
Medicine (Baltimore). 2020 Nov 13;99(46):e23249. doi: 10.1097/MD.0000000000023249.
Dopamine, Alpha-Synuclein, and Mitochondrial Dysfunctions in Parkinsonian Eyes
Indrieri A, Pizzarelli R, Franco B, De Leonibus E.
Front Neurosci. 2020 Oct 19;14:567129. doi: 10.3389/fnins.2020.567129. eCollection 2020.
[Neuroendocrine and metabolic impairments in patients with Parkinson's disease]
Verugina NI, Levin OS, Lyashenko EA.
Zh Nevrol Psikhiatr Im S S Korsakova. 2020;120(10. Vyp. 2):67-73. doi: 10.17116/jnevro202012010267.
Parkinson's disease and translational research
Dinter E, Saridaki T, Diederichs L, Reichmann H, Falkenburger BH.
Transl Neurodegener. 2020 Dec 1;9(1):43. doi: 10.1186/s40035-020-00223-0.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.